Change in lipoperoxidation but not in scavenging enzymes activity during polyamine embryoprotection in rat embryo cultured in hyperglycemic media

In Vitro Cellular and Developmental Biology - Animal

Volumn 48, Issue 9, 2012, Pages 570-576

  Chirino Galindo, Gladys ^a   Mejía Zepeda, Ricardo ^a   Palomar Morales, Martín ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Embryoprotection; Lipoperoxidation; Oxidative stress; Polyamines; Scavenging enzymes

Indexed keywords

ARGININE; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; POLYAMINE; PROTECTIVE AGENT; PUTRESCINE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SPERMIDINE; SUPEROXIDE DISMUTASE;

ANIMAL; ANIMAL EMBRYO; ARTICLE; CULTURE MEDIUM; DRUG EFFECT; EMBRYO CULTURE; ENZYMOLOGY; FEMALE; LIPID PEROXIDATION; MALE; METABOLISM; OXIDATIVE STRESS; RAT;

ANIMALS; ARGININE; CULTURE MEDIA; EMBRYO CULTURE TECHNIQUES; EMBRYO, MAMMALIAN; FEMALE; FREE RADICAL SCAVENGERS; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; POLYAMINES; PROTECTIVE AGENTS; PUTRESCINE; RATS; REACTIVE OXYGEN SPECIES; SPERMIDINE; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 84872033494     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-012-9548-2     Document Type: Article

References (55)

1. Abramov J. P.; Wells P. G. Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice. FASEB J 25: 2188-2200; 2011a.
2. Abramov J. P.; Wells P. G. Embryoprotective role of endogenous catalase in acatalasemic and human catalase-expressing mouse embryos exposed in culture to developmental and phenytoinenhanced oxidative stress. Toxicol Sci 120: 428-438; 2011b.
3. Aebi H. E. Oxidoreductases acting on groups other than CHOH. 3.9 Catalase: hydrogen-peroxidase: hydrogen-peroxidase oxidoreductase E.C. 1.11.1.6. In: Bergmeyer H. U. (ed) Methods of enzymatic analysis, vol. 3. Weinheim, Verlag Chemie, pp 273-286; 1983.
4. Beauchamp C.; Fridovich I. Superoxide dismutase: improved assays and assay aplicable to acrylamide gels. Analyt Biochem 44: 276-287; 1971.
5. Bellé N. A. V.; Dalmolin G. D.; Fonini G.; Rubin M. A.; Rocha J. B. T. Polyamines reduces lipid peroxidation induced by different prooxidant agents. Brain Res 1008: 245-251; 2004.
6. Cederberg J.; Eriksson U. H. Decreased catalase activity in malformation-prone embryos of diabetic rats. Teratology 56: 350-357; 1997.
7. Cederberg J.; Eriksson U. H. Antioxidative treatment of pregnant diabetic rats diminishes embryonic dysmorphogenesis. Birth Def Res (Part A) 73: 498-505; 2005.
8. Cederberg J.; Galli J.; Holger L.; Eriksson U. Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. Diabetes 49: 101-107; 2000.
9. Cederberg J.; Simán C. M.; Eriksson U. J. Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res 49: 755-762; 2001.
10. Chirino-Galindo G.; Baiza-Gutman L. A.; Barrera-Escorcia E.; Palomar-Morales M. Polyamines protect rat embryo in vitro from high glucose-induced developmental delay and dysmorphogenesis. Birth Def Res (Part B) 86: 58-64; 2009.
11. Das K. C.; Misra H. P. Hydroxyl radical scavenging and singlet oxygen quenching properties of polyamines. Mol Cell Biochem 262: 127-133; 2004.
12. El-Bassiouni E. A.; Helmy M. H.; Rawash N. A.; El-Zoghby S. M.; Kamel M. A. E. Rayah ANA. Embryopathy in experimental diabetic gestation: assessment of oxidative stress and antioxidant defense. Br J Biomed Sci 62: 71-76; 2005.
13. Forsberg H.; Borg L. A.; Cagliero E.; Eriksson U. J. Altered levels of scavenging enzymes in embryos subjected to a diabetic environment. Free Radic Res 24: 451-459; 1996.
14. Fozard J. R.; Prat M. L.; Nellikunja J. P.; Grove J. Inhibition of murine embryonic development by α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. Eur J Pharmacol 65: 379-391; 1980a.
15. Fozard J. R.; Prat M. L.; Prakash N. J.; Grove J.; Schechter P. J.; Sjoerdsma A.; Koch-Weser J. L-Ornithine decarboxylase: an essential role in early mammalian embryogenesis. Science 208: 505-509; 1980b.
16. Fujinaga M.; Baden J. M. Variation in development of rat embryos at the presomite period. Teratology 45: 661-670; 1992.
17. Grassilli E.; Desiderio M. A.; Bellesia E.; Salomoni P.; Benatti F.; Franceschi C. Is polyamine decrease a common feature of apoptosis? Evidence from γ rays-And heat shock induced cell death. Biochem Biophys Res Commun 216: 708-714; 1995.
18. Guérin P.; Mouatassim S. E.; Ménézo Y. Oxidative stress and protection against reactive species in the pre-implantation embro and its surroundings. Hum Reprod Upd 7: 175-189; 2001.
19. Ha H. A.; Sirisoma N. S.; Kuppusamy P.; Zweier J. L.; Woster P. M.; Casero Jr. R. The natural polyamine spermine functions directly as a free radical scavenger. Proc Natl Acad Sci 95: 11140-11145; 2006.
20. Klug S.; Lewandowski C.; Neubert D. Modification and standardization of the culture of early postimplantation embryos for toxicological studies. Arch Toxicol 58: 84-88; 1985.
21. Lowry O. H.; Rosebrough N. J.; Farr A. L.; Randall R. J. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275; 1951.
22. Mannen C. A.; Hood R. D.; Farina J. Ornithine decarboxylase inhibitors and fetal growth retardation in mice. Teratology 28: 237-242; 1983.
23. Marx M.; Trittenwein G.; Aufricht C.; Hoeger H.; Lubec B. Agmatine and spermidine reduce collagen accumulation in kidneys of diabetic db/db mice. Nephron 69: 155-158; 1995.
24. Méndez J. D. Polyamines and human reproduction. In: Bachrach U.; Heimer Y. (eds) The physiology of polyamines, vol. 1. CRC Press, Florida, pp 23-38; 1989.
25. Mendez J. D.; Balderas F. Inhibition by L-Arginine and spermidine of hemoglobin glycation and lipid peroxidation in rats with induced diabetes. Biomed Pharmacother 60: 26-31; 2006.
26. Méndez J. D.; Díaz-Flores M.; Durán G.; Hicks J. J. Inhibition of rat embryonic development by the intrauterine administration of α-difluoromethylornithine. Contraception 28: 93-98; 1983.
27. Méndez J. D.; Palomar-Morales M. Embryotoxicity for diabetes induced in rat: prevention for L-Arginine and polyamines. Reprod Toxicol 13: 501-509; 1999.
28. Miller L.; Wells P. G. Altered methanol embryopathies in embryo culture with mutant catalase-deficient mice and transgenic mice expressing human catalase. Toxicol Appl Pharmacol 252: 55-61; 2011.
29. Muzikova E.; Clark D. A. Polyamines may increase the percentage of in-vitro fertilized murine oocytes that develop into blastocysts. Human Reprod 10: 1172-1177; 1995.
30. New D. A. T. Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol Rev 53: 81-122; 1978.
31. Nitta T.; Igarashi K.; Yamashita A.; Yamamoto M.; Yamamoto N. Involvement of polyamines in B cell receptor-mediated apoptosis: spermine functions as a negative modulator. Exp Cell Res 265: 174-183; 2001.
32. Okhawa H.; Ohishi W.; Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analyt Biochem 95: 351-358; 1979.
33. Ornoy A. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol 24: 31-41; 2007.
34. Ornoy A.; Rand S. B.; Bischitz N. Hyperglycemia and hypoxia are interrelated in their teratogenic mechanism: Studies on cultured rat embryos. Birth Def Res (Part B) 89: 106-115; 2010.
35. Ornoy A.; Zaken V.; Kohen R. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies. Teratology 60: 376-386; 1999.
36. Paglia E. D.; Valentine N. W. Studies on the quantitative and qualitative characterization of erythocyte glutathione peroxidase. J Lab Clin Med 70: 158-168; 1967.
37. Pendeville H.; Carpino N.; Marine J. C.; Takahashi Y.; Muller M.; Martial J. A.; Cleveland J. L. The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol. Cell. Biol. 21: 6549-6558; 2001.
38. Penning L. C.; Schipper R. G.; Vercammen D.; Verhofstad A. A.; Denecker T.; Beyaert R.; Vandenabeele P. Sensitization of TNFinduced apoptosis with polyamine synthesis inhibitors in different human and murine tumour cell lines. Cytokine 10: 423-431; 1998.
39. Reece E. A. Maternal fuels, diabetic embryopathy: pathomechanisms and prevention. Semin Reprod Endocrinol 17: 183-194; 1999.
40. Sadler T.W.; Denno K. M.; Hunter 3rd E. S. Effects of altered maternal metabolism during gastrulation and neurulation stages of embryogenesis. Ann N Y Acad Sci 678: 48-61; 1993.
41. Seiler N.; Raul F. Polyamines and apoptosis. J Cell Mol Med 9: 623-642; 2005.
42. Singh C. K.; Kumar A.; Hitchcock D. B.; Fan D.; Goodwin R.; LaVoie H. A.; Nagarkatti A.; DiPette D. J.; Singh U. S. Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. Mol Nutr Food Res 55: 1-11; 2011.
43. Sivan E.; Lee Y. C.; Wu Y. K.; Reece E. A. Free radical scavenging enzymes in fetal dismorphogenesis among offspring of diabetic rats. Teratology 56: 343-349; 1997.
44. The Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the diabetes control and complications trial. Am J Obstet Gynecol 174: 1343-1353; 1996.
45. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167; 2003.
46. Thomas T.; Balabhadrapathruni S.; Gardner C. R.; Hong J.; Faaland C. A.; Thomas T. J. Effects of epidermal growth factor on MDAMB-468 breast cancer cells: alterations in polyamine biosynthesis and the expression of p21/CIP1/WAF1. J Cell Physiol 179: 257-266; 1999.
47. Thurman R. G.; Ley H. G.; Scholz R. Hepatic microsomal ethanol oxidation. Hydrogen peroxide formation and the role of catalase. Eur J Biochem 25: 420-430; 1972.
48. Trocino R. A.; Akazawa S.; Ishibashi M.; Matsumoto K.; Matsuo H.; Yamamoto H.; Goto S.; Urata Y.; Kondo T.; Nagataki S. Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44: 992-998; 1995.
49. Wentzel P.; Eriksson U. J. A diabetes-like environment increases malformation rate and diminishes prostaglandin E2 in rat embryos: reversal by administration of vitamin E and folic acid. Birth Def Res (Part A) 73: 506-511; 2005.
50. Wentzel P.; Gäreskog M.; Eriksson U. J. Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats. Diabetes 57: 3344-3352; 2008.
51. Wentzel P.; Wentzel C. R.; Gäreskog M. F.; Eriksson U. J. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 63: 193-201; 2001.
52. Yang X.; Borg L. A.; Eriksson U. J. Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272(1 pt 1): E173-E180; 1997.
53. Zabihi S.; Eriksson U. J.; Wentzel P. Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats. Reprod Toxicol 23: 486-498; 2007.
54. Zaken V.; Kohen R.; Ornoy A. Vitamins C and E improve rat embryonic antioxidant defense mechanism in diabetic culture medium. Teratology 64: 33-44; 2001.
55. Zangen S. W.; Ryu S.; Ornoy A. Alterations in the expression of antioxidant genes and the levels of transcription factor NFKappa B in relation to diabetic embryopathy in the Cohen diabetic rat model. Birth Def Res (Part A) 76: 107-114; 2006.